Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
New study reveals sex differences in cerebrospinal fluid biomarkers of Alzheimer’s disease prior to symptom onset
These findings reinforce the robustness of current CSF tools for early detection while encouraging sex-aware interpretation when tracking disease biology over time
The BBRC joins a Europe-wide project on menopause and brain health
MENOBRAIN will help uncover how menopause-related changes drive brain ageing and Alzheimer’s risk.
We are driving the development of a pioneering algorithm to anticipate the first symptoms of Alzheimer's
The ALFA10 study seeks to identify people at higher risk of developing Alzheimer's, even before the first symptoms appear
The PENSA study concludes with a farewell event for its participants
After five years of research and the participation of around one hundred volunteers, the PENSA study concludes with a closing gathering to share the study’s results with the participants.
The Pasqual Maragall Foundation announces the winners of the third edition of the Alzheimer's research grants
The two selected projects aim to promote innovative approaches to the prevention and treatment of Alzheimer's disease.
We organise an event on clinical PET in Alzheimer’s in the framework of the EANM 2025
50 people joined this satellite event with the aim of aligning clinical practice and research on amyloid, FDG and tau PET in the era of disease-modifying therapies.
We participate once again in the OpenPRBB
During the open day, we brought Alzheimer’s research closer to more than a thousand people with a hands-on workshop and a talk on prevention and healthy lifestyle habits.
We take part in the outreach initiative “European Researchers’ Night”
The European Researchers’ Night is held every year on the last Friday of September in more than 300 cities across 30 European countries
The European Commission authorizes the marketing of donanemab for the treatment of early-stage Alzheimer’s
Following the positive opinion from the EMA in July, the European Commission has now authorized the marketing of the drug.
